AXV-201

N/A

Report date: 2025/06/10 16:12:10

Base Information

Drug NameAXV-201
Drug Alias NameAXV-201
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionMelanocortin receptor 4 replacements
TargetsMelanocortin receptor 4
Therapy Area/IndicationsObesityCiliopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAxovia Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAxovia Therapeutics LtdAxovia Therapeutics
Inactive CompaniesN/A
Active IndicationsObesityCiliopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A